Eastern Cooperative Oncology Group is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
Eastern Cooperative Oncology Group has participated in 45 clinical trials with 5 currently active.
Therapeutic areas: Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma.
Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.
Trust Score: 78/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Eastern Cooperative Oncology Group has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Eastern Cooperative Oncology Group has 45 clinical trials on record, with 5 currently active. Their work covers Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma.
Eastern Cooperative Oncology Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.